Personalized treatment for rare melanoma in the mouth
Part of Cancer, Mouth & dental clinical trials.
This study is for people with a rare type of melanoma that starts inside the mouth. Researchers will use detailed testing to classify the cancer and help guide more personalized treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with melanoma that started in your mouth (not on your skin or elsewhere).
- You must be at least 18 years old.
- You should be getting or planning to get standard treatment such as surgery, radiation, chemotherapy, immunotherapy, or targeted therapy.
- You need to have your medical records (like biopsy and scan results) available, or be willing to participate in long-term follow-up visits.
- You cannot have another active cancer that could affect your treatment or outlook.
- You must be able to follow the study plan and give your permission to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving pembrolizumab (an immunotherapy) together with a targeted form of radiation can help after surgery for mucosal melanoma. It aims to lower the chance of the cancer coming back and improve outcomes in people whose tumor was removed.
This Phase 2 study tests medicines given before surgery for stage III/IV oral squamous cell carcinoma, choosing the treatment based on your tumor marker results. It aims to shrink the cancer and improve outcomes by using two targeted types of therapy.
This trial tests a combination of three drugs (pucotenlimab, lenvatinib, and temozolomide) given before surgery for head and neck mucosal melanoma. The goal is to see if this therapy can shrink the tumor and improve outcomes.
This trial studies how well two medicines—axitinib and nivolumab—work for people with advanced melanoma that starts in moist “mucosal” areas (like the mouth, nose, throat, or bowel). It may help shrink tumors and control the disease by boosting the immune system and targeting tumor growth.
This study tests whether a personalized approach to radiation therapy after surgery, guided by a special lymph node biopsy (sentinel node biopsy), can effectively treat mouth cancer while reducing side effects. It is for people whose cancer is on one side of the mouth and has not spread to the other side of the neck or beyond.
This study helps doctors plan surgery more individually for early-stage oral (mouth) squamous cell carcinoma. It focuses on using tumor features found during evaluation to guide surgical decisions, aiming to improve treatment accuracy.
Hear when a new Mucosal Melanoma of the Head and Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.